Patents
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
03/2008
03/05/2008EP1893574A2 Peptide deformylase (pdf) inhibitors 4
03/05/2008EP1893573A1 Inhibitors of hcv replication
03/05/2008EP1893197A1 Chromane substituted benzimidazole derivatives as acid pump antagonists
03/05/2008EP1633748B1 Quinoline derivatives as phosphodiesterase inhibitors
03/05/2008EP1575926B1 New pyridazin-3(2h)-one derivatives
03/05/2008EP1045836B1 Pyridones as src family sh2 domain inhibitors
03/05/2008CN101137650A 2-[(isoquinolin-3-carbonyl)amino]-propionic acid derivatives as inhibitors of factors xi and ix for the treatment of thrombosis
03/05/2008CN101137649A Alkinyl-oxypyrimidine used in the form of pesticides
03/05/2008CN101137643A Novel pyridine compounds
03/05/2008CN101137622A Substituted gamma lactams as therapeutic agents
03/05/2008CN101137414A 多环双酰胺mmp抑制剂 Polycyclic bisamides mmp inhibitors
03/05/2008CN100372840C Intermediate for the preparation of epimino
03/05/2008CN100372838C Piperidine-benzenesulfonamide derivatives
03/05/2008CN100372532C Imidazolin-2-ylaminophenyl amides as IP antagonists.
03/04/2008US7338969 Acyclic, aromatic, heteroaromatic and cyclic ring containing amido-derivatives, useful as antibacterial agent; inhibition of formation of biofilms in personal hygiene articles, toileteries, cosmetics and in industrial settings like ship hulls, food processing systems, oil recovery or paper making plants
03/04/2008US7338965 Enzyme inhibitors of beta-secretase which cleaves amyloid precursor protein present in Alzheimer's disease; Trisomy 21 (Down's Syndrome); Hereditary Cerebral Hemorrhage; cognition activators; Parkinson's disease
03/04/2008US7338959 N2-isopropyl-N5,1-dimethyl-N5-[2-({4-[(methylsulfonyl)methyl]phenyl}amino)pyrimidin-4-yl]-1H-benzimidazole-2,5-diamine; vascular endothelial growth factor (VEGF) receptor-2 and tyrosine kinase containing Ig and EGF homology domains (TIE) -2 inhibitor; antiproliferation and antihypoxic agent
03/04/2008US7338956 Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals
03/04/2008US7338950 Amide compounds as ion channel ligands and uses thereof
03/04/2008US7338947 monocyte chemotactic proteins (MCP)-1 receptor antagonist or agonist; 2-{1-[(1,2-cis)-2-(4-Methylsulfanyl-benzoylamino)-cyclohexyl]-2-oxo-pyrrolidin-3-ylcarbamoyl}-4-trifluoromethyl-phenyl)-carbamic acid tert-butyl ester; antiinflammatory agent, antiallergen; asthma, rheumatoid arthritis, atherosclerosis
02/2008
02/28/2008WO2008024974A1 Pyrimidine and pyrazine derivatives
02/28/2008WO2008024433A2 Haloalkyl-substituted pyrimidinone derivatives
02/28/2008WO2008023783A1 Amine compound
02/28/2008WO2008023235A1 Pyrazole derivatives as anti-platelet and anti-thrombotic agents
02/28/2008WO2008023159A1 Morpholino pyrimidine derivatives useful in the treatment of proliferative disorders
02/28/2008WO2008022979A1 New pyridone derivatives with mch antagonistic activity and medicaments comprising these compounds
02/28/2008WO2008022937A1 Thiophene-sulfonic acid picolyl amides
02/28/2008US20080051435 Crystalline and amorphous forms of tiagabine
02/28/2008US20080051374 ophthalmically acceptable for reducing intraocular pressure
02/28/2008CA2661827A1 Therapeutic substituted thiazolidinones, oxazolidinones, and related compounds
02/28/2008CA2657344A1 Thiophene-sulfonic acid picolyl amides
02/28/2008CA2657183A1 New pyridone derivatives with mch antagonistic activity and medicaments comprising these compounds
02/27/2008EP1892239A1 Inhibitors of cytosolic phospholipase A2
02/27/2008EP1891951A1 Viral polymerase inhibitors
02/27/2008EP1891950A1 Viral polymerase inhibitors
02/27/2008EP1891065A1 Novel mchr1 antagonists and their use for the treatment of mchr1 mediated conditions and disorders
02/27/2008EP1891058A1 Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
02/27/2008EP1891019A2 2,6-substituted-4-monosubstitutedamino-pyrimidine as prostaglandin d2 receptor antagonists
02/27/2008EP1891011A1 Tetrahydroquinolines used in the form of modulators of mitotic motor-proteins eg5
02/27/2008EP1891001A1 SULFONAMIDE DERIVATIVES USEFUL AS LIVER CARNITINE PALMITOYL TRANSFERASE (L-CPTl) INHIBITORS
02/27/2008EP1890703A2 Pyrimidine compounds
02/27/2008EP1395564B1 Quinoline derivatives as ligands for the neuropeptide y receptor
02/27/2008EP1246806B1 Arly- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
02/27/2008CN101133052A 1-arylpyrazoles and their use as pesticides
02/27/2008CN101133036A Novel benzimidazole derivatives useful as selective androgen receptor modulators (SARMS)
02/27/2008CN101133034A Substituted indazolyl sulfonamide and 2,3-dihydro-indolyl sulfonamide compounds, their preparation and use in medicaments
02/27/2008CN101133024A Amide derivatives as inhibitors of histone deacetylase
02/27/2008CN101130514A Intermediate for the preparation of epimino
02/27/2008CN100371329C Novel pyrimidine-4,6-dicarboxamides for the selective inhibition of collagenases
02/27/2008CN100370980C C-2' methylated derivatives of paclitaxel for use as antitumour agents
02/27/2008CA2660758A1 Morpholino pyrimidine derivatives useful in the treatment of proliferative disorders
02/26/2008US7335779 Acyclic, aromatic, heteroaromatic and cyclic ring containing amido-derivatives, useful as antibacterial agent
02/26/2008US7335774 Quinolinone derivatives
02/26/2008US7335677 Inhibitors of dipeptidyl peptidase IV
02/26/2008US7335676 Methods for treating inflammatory conditions or inhibiting JNK
02/26/2008US7335670 Specific inhibitors of the glycine transporters glyt1 and/or glyt2; psychoses, contracture, pain, Parkinson's disease, epilepsy, and sleep apnea
02/26/2008US7335666 That inhibit serotonin reuptake and are antagonists of the 5HT1A receptor; 2-[3-(6-Fluoro-indol-1-ylmethyl)-azetidin-1-ylmethyl]-8-methyl-2,3-dihydro-[1,4]dioxino[2,3-f]quinoline for example
02/26/2008US7335665 Spirocyclic piperidines as MCH1 antagonists and uses thereof
02/26/2008US7335660 Using a 2-benzopyran-6-carboxamide compound
02/26/2008US7335656 Medical devices employing triazine compounds and compositions thereof
02/26/2008US7335649 3-{N'-[1-(3,4-dimethylphenyl)-3-methyl-5-oxo-1,5-dihydropyrazol-4-ylidene]hydrazino}-2-hydroxy-3'-(tetrazol-5-yl)biphenyl for treatment of thrombocytopenia; colony stimulating factors
02/21/2008WO2008022013A1 Kinase inhibitors
02/21/2008WO2008021933A2 N-aryl or n-heteroaryl pyrazolidine and pyrazolidinone derivatives as prostaglandine receptor inhibitors
02/21/2008WO2008021518A2 Crystalline forms of tiagabine hydrochloride and processes for the preparation of amorphous tiagabine hydrochloride
02/21/2008WO2008020902A1 Substituted spirocyclic cgrp receptor antagonists
02/21/2008WO2008020607A1 Phthalide derivative and salt thereof
02/21/2008WO2008020306A2 Isoindole derivatives
02/21/2008WO2008020045A1 Tetrahydrobenzothiophene derivatives
02/21/2008WO2007149512A3 Peptide epoxyketones for pr0teas0me inhibition
02/21/2008WO2007149448A3 Pyrazinones as cellular proliferation inhibitors
02/21/2008WO2007121389A3 4,4-disubstituted piperidine derivatives as nk-i and serotonin transporter inhibitors
02/21/2008US20080045581 Ppar active compounds
02/21/2008US20080045576 Therapeutic n-aryl or n-heteroaryl pyrazolidine and pyrazolidinone derivatives
02/21/2008US20080045570 To treat autoimmune, inflammatory, proliferative, hyperproliferative,neurodegenerative or immunologically-mediated diseases; useful for the study of kinases in biological and pathological phenomena; study of intracellular signal transduction pathways mediated by such kinases, and comparative evaluation
02/21/2008US20080045560 Pyrrolidine and related derivatives useful as PR modulators
02/21/2008US20080045541 Dihydropyridinone Derivatives
02/21/2008US20080045540 Sulfonyl pyrrolidines, method for producing the same and their use as drugs
02/21/2008US20080045524 Selective NPY (Y5) antagonists
02/21/2008US20080045521 Phenylalanine derivatives
02/21/2008US20080045493 such as Parkinson's disease, schizophrenia, cognitive disorders, depression, anxiety, drug addiction, eating disorders and urogenital disorders; 4-(2,2-Difluoro-cyclopropyl)-N-[4-(1-propyl-piperidin-3-yl)-phenyl]-benzenesulfonamide
02/21/2008US20080044738 Salt suitable for an acid generator and a chemically amplified positive resist composition containing the same
02/21/2008CA2661006A1 Crystalline and amorphous forms of tiagabine
02/21/2008CA2661003A1 Crystalline forms of tiagabine hydrochloride
02/21/2008CA2660608A1 Therapeutic lactams
02/21/2008CA2660604A1 Tetrahydrobenzothiophene derivatives
02/21/2008CA2660474A1 Arylpiperazine derivatives and uses thereof
02/21/2008CA2660308A1 Therapeutic n-aryl or n-heteroaryl pyrazolidine and pyrazolidinone derivatives
02/21/2008CA2658960A1 Phenyl, pyridine and quinoline derivatives
02/21/2008CA2650932A1 Substituted spirocyclic cgrp receptor antagonists
02/20/2008EP1889843A1 Bisheterocycle tandem compounds useful as antiviral agents, the uses thereof and the compositions comprising such compounds
02/20/2008EP1889842A1 Heterocyclic compound
02/20/2008EP1889838A1 Thrombopoietin mimetics
02/20/2008EP1888575A2 Compounds for modulating trpv3 function
02/20/2008EP1888574A2 New antibiotic derivatives
02/20/2008EP1888569A1 Substituted piperidines as renin inhibitors
02/20/2008EP1888568A2 Substituted benzimidazole compounds with dual nos inhibitory activity and muopioid agonist activity
02/20/2008EP1888567A1 Heteroaryl-carboxylic acid (sulfamoyl alkyl) amide - derivatives as factor xa inhibitors
02/20/2008EP1888566A1 2-[(isoquinolin-3-carbonyl)amino]-propionic acid derivatives as inhibitors of factors xi and ix for the treatment of thrombosis
02/20/2008EP1888559A2 Piperazine-piperidine antagonists and agonists of the 5-ht1a receptor
02/20/2008EP1888538A1 (3,4-dihydro-quinazolin-2-yl)-(2-aryloxy-ethyl)-amines having an activity on the 5-ht receptor